Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
6 studies found for:    12435254 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Not yet recruiting Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease;   Diabetes Mellitus, Type 2
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel;   Drug: Aspirin
2 Terminated Pharmacodynamic Study on Efficacy of Clopidogrel With St. John's Wort
Condition: Acute Coronary Syndrome
Interventions: Drug: Placebo;   Drug: St. Johns Wort
3 Completed Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI
Condition: Coronary Artery Disease
Intervention: Drug: unfractionated heparin
4 Completed ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial
Condition: Coronary Occlusions
Intervention: Device: Cypher sirolimus eluting coronary stent
5 Unknown † The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial)
Conditions: Myocardial Infarction;   Coronary Artery Disease
Intervention: Procedure: coronary balloon-angioplasty with stenting
6 Completed 75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
Condition: Coronary Disease
Intervention: Drug: Clopidogrel
To Top

† Indicates status has not been verified in more than two years